Predicting Normal-Tension Glaucoma
August 12, 2025
New IOVS study recommends a polygenic approach towards advancing risk stratification in normal-tension glaucoma
2 min read
False
Advertisement
2025
Exonate Initiates Phase IIb Trial of EXN407 for Diabetic Eye Disease
August 12, 2025
EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema
1 min read
Death of the Salesman
August 11, 2025
How surgeons can free themselves of the salesperson persona while maintaining premium procedure conversion rates
4 min read
Diet & Sleep Links to Glaucoma
August 11, 2025
Diet, sleep, and biochemical mediators: novel insights into glaucoma pathogenesis
Phase III Data on Bausch + Lomb's LUMIFY®
August 8, 2025
Publication of phase III data on LUMIFY® preservative-free redness reliever eye drops
1 min read
Business and Entrepreneurship
Business and Entrepreneurship
Latest
Health Economics and Policy
Cornea
Glaucoma
Retina
Refractive
Also in the News…
August 8, 2025
The Ophthalmologist brings you the top news stories and studies of the week
3 min read
Laser-Induced Polymer Fragmentation in IOLs
August 7, 2025
Even with the finest skills, technique, devices and experience, performance suffers when clarity is compromised
5 min read
Glaucoma UK Names 2025 Grant Winners
August 7, 2025
Three glaucoma projects share a grant total of just under £240,000
5 min read
EyePoint Completes Enrollment of Phase III Trials for DURAVYU
August 6, 2025
One of the fastest enrolling phase III pivotal programs for wet AMD
3 min read
Browse by Subspecialties
False
Advertisement